Drug Type Biosimilar, Fusion protein |
Synonyms- |
Target |
Mechanism LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 3 | US | 15 Jan 2020 | |
Plaque psoriasis | Phase 3 | HU | 15 Jan 2020 | |
Plaque psoriasis | Phase 3 | IN | 15 Jan 2020 | |
Plaque psoriasis | Phase 3 | PL | 15 Jan 2020 | |
Plaque psoriasis | Phase 3 | SK | 15 Jan 2020 | |
Plaque psoriasis | Phase 3 | ES | 15 Jan 2020 |